Table IV.
Adverse reaction | High-risk group (n=67) | Moderate-risk group (n=58) | Low-risk group (n=82) | F value | P-value |
---|---|---|---|---|---|
Bone marrow suppression | 9 (13.43) | 4 (6.90) | 1 (1.22) | 0.039 | 0.962 |
Gastrointestinal reaction | 24 (35.82) | 18 (31.03)a | 11 (13.41)a | 0.099 | 0.908 |
Skin allergic reaction | 9 (13.43) | 7 (12.07)a | 2 (2.44)a | 0.042 | 0.959 |
Liver function injury | 5 (7.46) | 3 (5.17) | 2 (2.44) | 0.037 | 0.965 |
Respiratory tract reaction | 13 (19.40) | 6 (10.35) | 4 (4.88) | 0.048 | 0.954 |
Adverse reaction rate (%) | 60 (89.55) | 38 (65.52)a | 20 (24.39)a,b | 0.090 | 0.916 |
P<0.05, compared with the low-risk group
P<0.05, compared with the moderate-risk group.